Welcome to Coulter Partners Global (English)

25 January 2022

Top hires for VC & PE portfolio companies Q4-2021

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO RNA epigenetics Belgium
CEO Novel small molecules US
President US Immuno-oncology China
Chief Scientific Officer Oncology China
Chief Technology Officer Cardiovascular devices France
Chief Medical Officer Oncology and rare diseases UK
Chief Financial Officer Precision cancer therapeutics US
Chief Commercial Officer Digital pathology France
Regional Chief Financial Officer Veterinary services Nordics
SVP Biology Protein degradation therapeutics UK
SVP Chemistry RNA activation-based therapies UK
EVP Commercial Clinical research services Germany
VP Immunology Cell therapy Switzerland
Head of Project & Portfolio Management mRNA immunotherapies UK
2x Board Directors Autoimmunology disorders Denmark
Associate Life science venture capital Netherlands

Newly opened projects include:

Function Focus area Location
Group CEO Outpatient services Switzerland
CEO A.I. for drug discovery US
CEO Synthetic biology technologies UK
CEO Surgical robotics Switzerland
Chief Financial Officer RNA-based therapeutics Germany
Chief Medical Officer Oncology US
Chief Commercial Officer Rapid diagnostics Belgium
Chief Scientific Officer Protein degrading therapeutics US
SVP Clinical Development Digital therapeutics Nordics
Head of Sales, Americas A.I-enabled diagnostics Nordics
VP RA/QA CNS diseases Singapore
VP, Molecular Pharmacology RNA interference US
Chair Cardiac diseases Germany
Investment Manager Medtech growth investor Sweden


A new version of Coulter Partners is available.